[go: up one dir, main page]

WO2004096844A3 - Group 1 mite polypeptide variants - Google Patents

Group 1 mite polypeptide variants Download PDF

Info

Publication number
WO2004096844A3
WO2004096844A3 PCT/DK2004/000280 DK2004000280W WO2004096844A3 WO 2004096844 A3 WO2004096844 A3 WO 2004096844A3 DK 2004000280 W DK2004000280 W DK 2004000280W WO 2004096844 A3 WO2004096844 A3 WO 2004096844A3
Authority
WO
WIPO (PCT)
Prior art keywords
group
polypeptide variants
mite polypeptide
mite
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DK2004/000280
Other languages
French (fr)
Other versions
WO2004096844A2 (en
Inventor
Nanna Kristensen Soni
Esben Peter Friis
Erwin Ludo Roggen
Stina Thulesen Lyngstrand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes AS filed Critical Novozymes AS
Priority to JP2006504364A priority Critical patent/JP2007525155A/en
Priority to EP04729048A priority patent/EP1620461A2/en
Priority to CA002523402A priority patent/CA2523402A1/en
Priority to AU2004233940A priority patent/AU2004233940A1/en
Publication of WO2004096844A2 publication Critical patent/WO2004096844A2/en
Publication of WO2004096844A3 publication Critical patent/WO2004096844A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Insects & Arthropods (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

This invention concerns variants of group 1 mite polypeptides, wherein the mature polypeptide of the variant comprise one or more mutations in the positions or corresponding to the positions consisting of A10, A12, E13, G29, G30, G32, A46, Y47, S54, L55, D64, A66, S67, G73, T75, I80, Q84, N86, G87, S92, Y93, Y96, A98, R99, E100, Q101, R104, R105, P106, Q109, R110, F111, G112, I113, A132, I144, K145, D146, D148, R151, I158, I159, Q160, R161, D162, N163, G164, Y165, Q166, N179, A180, G182, V183, D184, A205, I208 of SEQ ID NO: 1 or 10, 12, 13, 29, 30, 32, 46, 47, 54, 55, 64, 66, 67, 73, 75, I80, 84, 86, 87, 92, Y93, 96, 98, 99, 100, 101, 104, 105, 106, 109, 110, 111, 112, 113, 132, 144, 145, 146, 148, 151, 158, 159, 160, 161, 162, 163, 164, 165, 166, 179, 180, 182, 183, 184, 205, 208 of the mature Der p 1 polypeptide.
PCT/DK2004/000280 2003-04-25 2004-04-23 Group 1 mite polypeptide variants Ceased WO2004096844A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2006504364A JP2007525155A (en) 2003-04-25 2004-04-23 Group 1 mite polypeptide variant
EP04729048A EP1620461A2 (en) 2003-04-25 2004-04-23 Group 1 mite polypeptide variants
CA002523402A CA2523402A1 (en) 2003-04-25 2004-04-23 Group 1 mite polypeptide variants
AU2004233940A AU2004233940A1 (en) 2003-04-25 2004-04-23 Group 1 mite polypeptide variants

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200300628 2003-04-25
DKPA200300628 2003-04-25
DKPA200301093 2003-07-21
DKPA200301093 2003-07-21

Publications (2)

Publication Number Publication Date
WO2004096844A2 WO2004096844A2 (en) 2004-11-11
WO2004096844A3 true WO2004096844A3 (en) 2004-12-16

Family

ID=33420357

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2004/000280 Ceased WO2004096844A2 (en) 2003-04-25 2004-04-23 Group 1 mite polypeptide variants

Country Status (5)

Country Link
EP (1) EP1620461A2 (en)
JP (1) JP2007525155A (en)
AU (1) AU2004233940A1 (en)
CA (1) CA2523402A1 (en)
WO (1) WO2004096844A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1756150A2 (en) * 2004-04-23 2007-02-28 Novozymes A/S Group 1 mite polypeptide variants
EP1756275A1 (en) * 2004-04-23 2007-02-28 Novozymes A/S Method for obtaining mature protease by enzymatic digestion

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5820862A (en) * 1994-04-14 1998-10-13 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
WO1999025823A2 (en) * 1997-11-19 1999-05-27 Smithkline Beecham Biologicals S.A. Recombinant allergen with reduced enzymatic activity
WO2001029078A2 (en) * 1999-10-15 2001-04-26 Heska Corporation Method for production and use of mite group 1 proteins
WO2001083559A2 (en) * 2000-04-28 2001-11-08 Novozymes A/S Production and use of protein variants having modified immunogenecity
WO2003016340A1 (en) * 2001-08-17 2003-02-27 Glaxosmithkline Biologicals S.A. Derp1 and proderp1 allergen derivatives

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5820862A (en) * 1994-04-14 1998-10-13 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
WO1999025823A2 (en) * 1997-11-19 1999-05-27 Smithkline Beecham Biologicals S.A. Recombinant allergen with reduced enzymatic activity
WO2001029078A2 (en) * 1999-10-15 2001-04-26 Heska Corporation Method for production and use of mite group 1 proteins
WO2001083559A2 (en) * 2000-04-28 2001-11-08 Novozymes A/S Production and use of protein variants having modified immunogenecity
WO2003016340A1 (en) * 2001-08-17 2003-02-27 Glaxosmithkline Biologicals S.A. Derp1 and proderp1 allergen derivatives

Also Published As

Publication number Publication date
CA2523402A1 (en) 2004-11-11
AU2004233940A1 (en) 2004-11-11
JP2007525155A (en) 2007-09-06
WO2004096844A2 (en) 2004-11-11
EP1620461A2 (en) 2006-02-01

Similar Documents

Publication Publication Date Title
EP1585582A4 (en) GAME SOFTWARE CONVERSION FOR LOTTERY APPLICATION
DE60205705D1 (en) Dental impression material with ruthenium metathesis catalyst
ZA200710905B (en) Flavoring of drug-containing chewing gums
DE60239210D1 (en) POLYMER TONE NANOVERAL COMPOSITION
DE60238054D1 (en) Coated Niko-containing chewing gum, its preparation and use
EP2154157A3 (en) FC region variants
ATE482949T1 (en) N-HETEROCYCLYL-PHENYL-SUBSTITUTED CYCLIC KETOENOLS
AU2002366138A1 (en) Interleaving order generator, interleaver, turbo encoder, and turbo decoder
AU2003265864A1 (en) In vivo production of cyclic peptides for inhibiting protein-protein interaction
NO20043053L (en) High molecular weight cationic anionic polymers comprising zwitterionic monomers
AU2003247680A1 (en) Molecular sieve catalyst composition
DK1397050T3 (en) Chewing gum to control bad breath
DE60201987D1 (en) HARDENABLE BASE-RESISTANT FLUORELASTOMERS
WO2004096844A3 (en) Group 1 mite polypeptide variants
IS7330A (en) Small hockey pitch
DE602004026627D1 (en) ORGANOMETALLIC TRANSITION METAL COMPOUND, BISCYD PREPARATION OF POLYOLEFINES
DE50304610D1 (en) PREPARATION OF STRUCTURED HARTCHROM LAYERS
DE60335998D1 (en) PIEZOELECTRIC PORCELAIN COMPOSITION, PIEZOELECTRIC ELEMENT AND MANUFACTURING METHOD THEREFOR
FI20080548L (en) Orodispersible tablets containing escitalopram base and method for their preparation
DE60312248D1 (en) Film-forming polyimide copolymer
DE60234796D1 (en) Signal structure as well as interleaving for multicarrier transmission
GB2396614C (en) Lewis acid catalyst composition
ITRM20020155A0 (en) "BRUSH TYPE" POLYMER COMPOSITE CHIRAL STATIONARY PHASES.
ITMI20021358A1 (en) CATALYST FOR THE PREPARATION OF PHTHALIC ANHYDRIDE
DE50014776D1 (en) Gas sensor with diffusion-limiting layer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004233940

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2004729048

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2523402

Country of ref document: CA

Ref document number: 2006504364

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 20048111066

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 2004233940

Country of ref document: AU

Date of ref document: 20040423

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004233940

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2004729048

Country of ref document: EP